Browse Tag

CEO changes

lululemon athletica (LULU) Stock News Today (Dec. 14, 2025): CEO Transition, Q3 Beat, Buyback Boost, and Nasdaq-100 Exit in Focus

lululemon athletica (LULU) Stock News Today (Dec. 14, 2025): CEO Transition, Q3 Beat, Buyback Boost, and Nasdaq-100 Exit in Focus

Lululemon (NASDAQ: LULU) stock is back in the spotlight after a Q3 earnings beat, updated fiscal 2025 guidance, a $1.0B buyback authorization increase, a CEO succession announcement, and confirmation it will be removed from the Nasdaq-100. Here’s what investors are
Recursion Pharmaceuticals (RXRX) – AI Drug Discovery Breakthroughs, CEO Shakeup & 2025 Stock Outlook

Recursion Pharmaceuticals (RXRX) – AI Drug Discovery Breakthroughs, CEO Shakeup & 2025 Stock Outlook

Below we dive into a detailed analysis of RXRX – covering the latest developments, the company’s AI-powered business model, financials, key partnerships, expert commentary, technical trends, forecasts, and how Recursion compares to other AI-focused biotech players. Latest Developments and News
Go toTop